The goal is to recognize those biological changes that underlie aberrant epigenetic programming of brain plasticity, and to recognize mitochondrial signaling pathways, metabolic factors, transcriptomic profiles and structural changes that indicate flexible adaptability or the lack thereof
Part 1: Big pharma eyes China at forefront of GLP-1 revolution Part 2: China biotechs rise to challenge Ozempic, Wegovy Part 3: Novo Nordisk seeks to repurpose GLP-1s, again, for the brain
It helps regulate insulin, reduce appetite, slow digestion, and improve blood sugar response
Yu D, Shen S, Zhang J, Wang Q
Andrew Huberman: I mean, quote unquote, "you feel it." Glen Jeffery: You feel it